EPCAM and hepatocellular carcinoma: In contrast to the healthy donor cohort, elevated Z scores for EpCAM protein and EpCAM mRNA were observed in the other cancer cohorts, whereas both the early‐stage and intermediate–advanced‐stage HCC cohorts presented varying degrees of elevation in Z scores across all the markers.